FMC Corporation (FMC) Receives $74.98 Average PT from Brokerages

Shares of FMC Corporation (NYSE:FMC) have earned an average recommendation of “Buy” from the nineteen brokerages that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and ten have given a buy rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $74.98.

Several equities analysts have recently commented on FMC shares. TheStreet raised shares of FMC Corporation from a “c+” rating to a “b-” rating in a research report on Thursday, May 4th. Credit Suisse Group set a $77.00 price target on shares of FMC Corporation and gave the stock a “buy” rating in a research report on Monday, April 3rd. SunTrust Banks, Inc. raised shares of FMC Corporation from a “hold” rating to a “buy” rating and increased their price target for the stock from $58.00 to $82.00 in a research report on Monday, April 3rd. They noted that the move was a valuation call. Seaport Global Securities raised shares of FMC Corporation from a “neutral” rating to a “buy” rating in a research report on Friday, March 31st. Finally, Royal Bank Of Canada reaffirmed a “buy” rating and set a $71.00 price target on shares of FMC Corporation in a research report on Tuesday, March 28th.

In related news, VP Andrea E. Utecht sold 14,434 shares of the firm’s stock in a transaction that occurred on Monday, May 15th. The shares were sold at an average price of $74.62, for a total transaction of $1,077,065.08. Following the transaction, the vice president now owns 131,899 shares in the company, valued at $9,842,303.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Mark Douglas sold 12,697 shares of the firm’s stock in a transaction that occurred on Wednesday, June 14th. The shares were sold at an average price of $75.82, for a total transaction of $962,686.54. Following the transaction, the insider now owns 73,690 shares in the company, valued at approximately $5,587,175.80. The disclosure for this sale can be found here. Insiders have sold 41,489 shares of company stock worth $3,118,310 in the last quarter. Company insiders own 1.10% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of FMC. Columbia Partners L L C Investment Management raised its position in FMC Corporation by 47.2% in the first quarter. Columbia Partners L L C Investment Management now owns 20,880 shares of the basic materials company’s stock valued at $1,453,000 after buying an additional 6,699 shares during the period. Aviance Capital Management LLC acquired a new position in FMC Corporation during the first quarter valued at about $200,000. Tower Research Capital LLC TRC raised its position in FMC Corporation by 70.8% in the first quarter. Tower Research Capital LLC TRC now owns 8,733 shares of the basic materials company’s stock valued at $608,000 after buying an additional 3,620 shares during the period. Cambridge Trust Co. acquired a new position in FMC Corporation during the first quarter valued at about $480,000. Finally, Bank of Nova Scotia acquired a new position in FMC Corporation during the first quarter valued at about $2,123,000. Hedge funds and other institutional investors own 91.11% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “FMC Corporation (FMC) Receives $74.98 Average PT from Brokerages” was reported by BBNS and is the property of of BBNS. If you are accessing this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The original version of this article can be accessed at https://baseballnewssource.com/markets/fmc-corporation-fmc-receives-74-98-consensus-price-target-from-brokerages-updated/985420.html.

Shares of FMC Corporation (NYSE:FMC) traded down 0.71% during midday trading on Friday, hitting $75.61. The company’s stock had a trading volume of 1,681,705 shares. The firm has a market cap of $10.13 billion, a price-to-earnings ratio of 283.18 and a beta of 1.61. FMC Corporation has a 12-month low of $41.80 and a 12-month high of $77.38. The firm has a 50-day moving average of $74.59 and a 200 day moving average of $64.80.

FMC Corporation (NYSE:FMC) last announced its earnings results on Tuesday, May 2nd. The basic materials company reported $0.43 earnings per share for the quarter, missing the consensus estimate of $0.56 by $0.13. The business had revenue of $596 million for the quarter, compared to analyst estimates of $742.50 million. FMC Corporation had a net margin of 1.19% and a return on equity of 17.87%. On average, equities research analysts predict that FMC Corporation will post $2.45 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 20th. Investors of record on Friday, June 30th will be paid a dividend of $0.165 per share. The ex-dividend date is Wednesday, June 28th. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.87%. FMC Corporation’s dividend payout ratio is presently 235.72%.

FMC Corporation Company Profile

FMC Corporation is a diversified chemical company serving agricultural, consumer and industrial markets. The Company operates in three business segments: FMC Agricultural Solutions, FMC Health and Nutrition, and FMC Lithium. As of December 31, 2016, the FMC Agricultural Solutions segment developed, marketed and sold three classes of crop protection chemicals: insecticides, herbicides and fungicides.

Receive News & Ratings for FMC Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FMC Corporation and related companies with our FREE daily email newsletter.

 


Latest News

Hitters in Major League Baseball on Record Home Run Pace
Hitters in Major League Baseball on Record Home Run Pace
Atlanta Considering Playing Freddie Freeman at Third
Atlanta Considering Playing Freddie Freeman at Third
Injury to Gleyber Torres Adds to Questions About Yankees
Injury to Gleyber Torres Adds to Questions About Yankees
Game Winning Home Run Completes Nolan Arenado Cycle
Game Winning Home Run Completes Nolan Arenado Cycle
New York Yankees and Masahiro Tanaka Hit Hard Again
New York Yankees and Masahiro Tanaka Hit Hard Again
Victor Martinez Diagnosed with Irregular Heartbeat
Victor Martinez Diagnosed with Irregular Heartbeat


Leave a Reply

 
© 2006-2017 BBNS.